Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

SM04755 may be an effective topical treatment for psoriasis.

Blocking LFA-1 prevents hair loss in mice.

Simvastatin reduces inflammation and promotes hair regrowth in alopecia areata.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Certain skin cells near the base of hair muscles may help renew and stabilize skin, possibly affecting skin disorder understanding.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

The document concludes that adult mammalian skin contains multiple stem cell populations with specific markers, important for understanding skin regeneration and related conditions.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Lack of Ctip2 in skin cells delays wound healing and disrupts hair follicle stem cell markers in mice.

Enzymes involved in Vitamin A metabolism affect hair growth and type in mice.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.